Gemcitabine hydrochloride

Name Gemcitabine hydrochloride
Supplier R&D Systems
Catalog 3259
Prices $109.00, $455.00
Sizes 10 mg, 50 mg
Cas Number 122111-03-9
Chemical Name (+)-2'-Deoxy-2',2'-difluorocytidinehydrochloride
Formula C9H11F2N3O4.HCl
Molecular Weight 299.66
Purity >99%
Supplier Page Shop

Product References

An automated fitting procedure and software for dose-response curves with - An automated fitting procedure and software for dose-response curves with

Di Veroli GY, Fornari C, Goldlust I, Mills G, Koh SB, Bramhall JL, Richards FM, Jodrell DI. Sci Rep. 2015 Oct 1;5:14701.

DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of - DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of

Dolman ME, van der Ploeg I, Koster J, Bate-Eya LT, Versteeg R, Caron HN, Molenaar JJ. PLoS One. 2015 Dec 30;10(12):e0145744.

Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR - Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR

Okita R, Wolf D, Yasuda K, Maeda A, Yukawa T, Saisho S, Shimizu K, Yamaguchi Y, Oka M, Nakayama E, Lundqvist A, Kiessling R, Seliger B, Nakata M. PLoS One. 2015 Oct 6;10(10):e0139809.

Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the - Selective inhibition of pancreatic ductal adenocarcinoma cell growth by the

Slee RB, Grimes BR, Bansal R, Gore J, Blackburn C, Brown L, Gasaway R, Jeong J, Victorino J, March KL, Colombo R, Herbert BS, Korc M. Mol Cancer Ther. 2014 Feb;13(2):307-15.

BRCA2 and RAD51 promote double-strand break formation and cell death in response - BRCA2 and RAD51 promote double-strand break formation and cell death in response

Jones RM, Kotsantis P, Stewart GS, Groth P, Petermann E. Mol Cancer Ther. 2014 Oct;13(10):2412-21.

Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy - Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy

Bapiro TE, Frese KK, Courtin A, Bramhall JL, Madhu B, Cook N, Neesse A, Griffiths JR, Tuveson DA, Jodrell DI, Richards FM. Br J Cancer. 2014 Jul 15;111(2):318-25.

Characterization of permeability, stability and anti-HIV-1 activity of decitabine - Characterization of permeability, stability and anti-HIV-1 activity of decitabine

Clouser CL, Bonnac L, Mansky LM, Patterson SE. Antivir Chem Chemother. 2014 Dec 16;23(6):223-30.

Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in - Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in

Song B, Liu XS, Rice SJ, Kuang S, Elzey BD, Konieczny SF, Ratliff TL, Hazbun T, Chiorean EG, Liu X. Mol Cancer Ther. 2013 Jan;12(1):58-68.